Full View

COPD maintenance therapy with tiotropium/olodaterol compared with tiotropium: an analysis in the absence of additional ICS therapy

PMA Calverley, A Hoz, W Xue… - COPD: Journal of …, 2020 - Taylor & Francis
Abstract The American Thoracic Society guidelines recommend long-acting β2-agonist
(LABA)/long-acting muscarinic antagonist (LAMA) dual bronchodilation over LAMA or LABA …
被引用次数：1 相关文章

COPD Maintenance Therapy with Tiotropium/Olodaterol Compared with Tiotropium: An Analysis in the Absence of Additional ICS Therapy.

PMA Calverley, A Hoz, W Xue, GT Ferguson… - COPD, 2020 - europepmc.org
The American Thoracic Society guidelines recommend long-acting β 2-agonist (LABA)/long-
acting muscarinic antagonist (LAMA) dual bronchodilation over LAMA or LABA monotherapy …
[PDF] core.ac.uk

[PDF][PDF] COPD Maintenance Therapy with Tiotropium/Olodaterol Compared with Tiotropium: An Analysis in the Absence of Additional ICS Therapy

PMA Calverley, A de la Hoz, W Xue… - COPD: JOURNAL OF …, 2020 - core.ac.uk
ABSTRACT The American Thoracic Society guidelines recommend long-acting b2-agonist
(LABA)/long-acting muscarinic antagonist (LAMA) dual bronchodilation over LAMA or LABA …

COPD Maintenance Therapy with Tiotropium/Olodaterol Compared with Tiotropium: An Analysis in the Absence of Additional ICS Therapy

PMA Calverley, A de la Hoz, W Xue, GT Ferguson… - COPD, 2020 - pubmed.ncbi.nlm.nih.gov
The American Thoracic Society guidelines recommend long-acting β 2-agonist (LABA)/long-
acting muscarinic antagonist (LAMA) dual bronchodilation over LAMA or LABA monotherapy …